A Single-centre Research Study to Evaluate the Care4Today® Heart Failure Platform.
1 other identifier
interventional
182
0 countries
N/A
Brief Summary
A research study to evaluate the impact of a novel care pathway for patients diagnosed with Heart Failure within Chiltern CCG, supported by an integrated clinical patient record. Assessment of patient outcomes following implementation of Care4Today(R) Heart Failure Platform.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2015
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 18, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 4, 2018
CompletedFirst Submitted
Initial submission to the registry
April 28, 2020
CompletedFirst Posted
Study publicly available on registry
May 1, 2020
CompletedMay 1, 2020
April 1, 2020
2.6 years
April 28, 2020
April 30, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Hospital admissions
number of hospital admissions
12 months
Secondary Outcomes (7)
mean number of heart failure readmissions within 30 days of discharge
30 days of discharge
all cause readmissions
12 months
length of stay
12 months
weight change
12 months
Blood pressure
12 months
- +2 more secondary outcomes
Study Arms (2)
Active Arm
EXPERIMENTALActive cohort will use the Care4today platform to help manage their heart failure
Control arm
NO INTERVENTIONControl arm will contain standard of care heart failure treatment
Interventions
Platform allowing patients to enter information about their health at home, namely weight and BP and medications
Eligibility Criteria
You may qualify if:
- Adults 18 years of age or older with the primary diagnosis of heart failure
- Must have moderate to severe LVSD (ejection fraction \<= 40%) confirmed by an echocardiogram and/or other cardiac imaging
You may not qualify if:
- Patients with right heart failure as a consequence of respiratory disease
- Patients with Heart Failure with preserved Ejection Fraction
- Patients with significant learning disability, or severe mental health conditions
- Patients with metabolic heart disease e.g. amyloid
- Patients with severe non-operable valve disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Buckinghamshire Healthcare NHS Trustlead
- Janssen-Cilag Ltd.collaborator
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2020
First Posted
May 1, 2020
Study Start
May 18, 2015
Primary Completion
December 12, 2017
Study Completion
April 4, 2018
Last Updated
May 1, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share